Mitotax 100mg Injection is a potent chemotherapy medication used in the treatment of various types of cancer. Its active ingredient, Paclitaxel, is a taxane-class antineoplastic agent. Paclitaxel works by disrupting the normal functioning of microtubules, which are essential components of cell division. By stabilizing microtubules, it prevents the breakdown of the mitotic spindle, leading to cell cycle arrest and ultimately programmed cell death (apoptosis) in rapidly dividing cancer cells.
Mitotax 100mg Injection is indicated for the treatment of advanced ovarian cancer, advanced breast cancer, and non-small cell lung cancer. It may also be used in combination with other chemotherapy drugs for various oncological conditions.
Dosage and administration should be strictly determined by a qualified healthcare professional based on the patient’s condition, response to treatment, and other individual factors. It is typically administered intravenously.
Common side effects may include bone marrow suppression (leading to low blood cell counts), peripheral neuropathy (nerve damage causing numbness or tingling), hair loss, nausea, vomiting, diarrhea, and allergic reactions. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately.
Mitotax 100mg Injection should be stored at room temperature (20°C to 25°C or 68°F to 77°F), protected from light. It should not be frozen. It is a prescription-only medication and should only be administered under medical supervision.
